Government's subsidy burden for FY25 is set to exceed budget estimates, rising to Rs 4.1-4.2 lakh crore, largely due to ...

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

Shares of Cyient Ltd fell 18.58% after weak Q3 FY25 results and CEO resignation. The DET segment saw a drop in YoY profit, ...

The government is expected to exceed its fiscal deficit consolidation target for FY25 due to slower-than-budgeted public ...

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

FY25 revenue grew by 26.2% YoY to $267.4 million, with a 31.2% increase in marketing and sales promotion expenses.

Syngene International declined 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Results: The company had last reported an EBITDA margin in excess of 20% in the fourth quarter of financial year 2023.

This financial performance was driven by significant greenfield capacity additions of 3.1 GW and consistent plant performance ...

The subsidy burden of the government is expected to rise to approximately Rs 4.1-4.2 lakh crore in the financial year 2024-25 (FY25) more than the budget estimates, according to a report by the Bank ...

Looking ahead, MarineMax backed its 2025 guidance, expecting adjusted per-share earnings between $1.80 and $2.80, as well as adjusted earnings before interest, taxes, depreciation and amortization ...

WNS (Holdings) shares jumped after the company raised its adjusted earnings outlook for the year, as it beat revenue expectations in its fiscal third quarter. The stock climbed 19%, to $58.97, in ...